We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Atea/Roche Antiviral COVID-19 Pill Fails in Phase 2 Study, Companies Still Hopeful
Atea/Roche Antiviral COVID-19 Pill Fails in Phase 2 Study, Companies Still Hopeful